Surgical excision of a metastatic adrenal lesion in a patient with prostatic cancer

被引：15
作者：
Sakamoto, N
Eto, M
Ando, S
机构：
[1] Kyushu Univ, Dept Urol, Fac Med, Higashi Ku, Fukuoka 8128582, Japan
[2] Nakatsu Natl Hosp, Dept Urol, Nakatsu, Japan
[3] Kitakyushu City Med Ctr, Kitakyushu, Fukuoka, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 1999年 / 6卷 / 01期
关键词：
adrenal metastasis; hormone refractory disease; prostatic cancer; surgical excision;
D O I：
10.1046/j.1442-2042.1999.06125.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Background: A 64-year-old Japanese man with stage D2 prostatic cancer, after having responded dramatically to androgen ablation, demonstrated a solitary adrenal metastasis without disease progression to any other site. Methods: A surgical excision of the lesion and adjuvant systemic chemotherapy was performed. Results/Conclusions: The patient has since remained alive without any evidence of recurrence 21 months after surgery.
引用
收藏
页码：38 / 40
页数：3
相关论文
共 12 条
[1]   EPIDIDYMAL METASTASIS FROM PROSTATIC-CARCINOMA [J].
ADDONIZIO, JC ;
THELMO, W .
UROLOGY, 1981, 18 (05) :490-491
[2]  
FAIR WR, 1992, CAMPBELLS UROLOGY, P1031
[3]   PHASE-II STUDY OF ESTRAMUSTINE AND VINBLASTINE, 2 MICROTUBULE INHIBITORS, IN HORMONE-REFRACTORY PROSTATE-CANCER [J].
HUDES, GR ;
GREENBERG, R ;
KRIGEL, RL ;
FOX, S ;
SCHER, R ;
LITWIN, S ;
WATTS, P ;
SPEICHER, L ;
TEW, K ;
COMIS, R .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1754-1761
[4]   THE TIMING OF ANDROGEN ABLATION THERAPY AND OR CHEMOTHERAPY IN THE TREATMENT OF PROSTATIC-CANCER [J].
ISAACS, JT .
PROSTATE, 1984, 5 (01) :1-17
[5]   ADRENAL INSUFFICIENCY AND STAGE-D CARCINOMA OF THE PROSTATE [J].
MIRTSCHING, BC ;
FREEMAN, DA .
SOUTHERN MEDICAL JOURNAL, 1992, 85 (02) :196-197
[6]  
MONTE SM, 1986, CANCER, V58, P985
[7]   ADDISONS-DISEASE SECONDARY TO PROSTATIC-CARCINOMA - A CASE-REPORT [J].
NAVARRO, M ;
FELIP, E ;
GARCIA, L ;
BELLMUNT, J ;
JOLIS, L ;
MORALES, S ;
RUBIO, D .
TUMORI, 1990, 76 (06) :611-613
[8]  
SAITOH H, 1984, CANCER-AM CANCER SOC, V54, P3078, DOI 10.1002/1097-0142(19841215)54:12<3078::AID-CNCR2820541245>3.0.CO
[9]  
2-U
[10]   ESTRAMUSTINE AND VINBLASTINE - USE OF PROSTATE SPECIFIC ANTIGEN AS A CLINICAL-TRIAL END-POINT FOR HORMONE REFRACTORY PROSTATIC-CANCER [J].
SEIDMAN, AD ;
SCHER, HI ;
PETRYLAK, D ;
DERSHAW, DD ;
CURLEY, T .
JOURNAL OF UROLOGY, 1992, 147 (03) :931-934
12